Syngenta may reconsider seed asset sale, investor group says
The potential change was disclosed in a Nov. 26 meeting with Demare, the Alliance of Critical Syngenta Shareholders said in a letter to its members, a copy of which was obtained by Bloomberg News. In recent months, the group has publicly opposed the sale of the seed assets and has criticized Syngenta’s management for the way it handled a takeover bid from Monsanto Co.
Syngenta announced in September plans divest the seed units and buy back more than $2 billion of shares. Vegetable seeds, which generated $663 million of revenue last year, could fetch more than $2.5 billion, analysts at Sanford C. Bernstein & Co. said at the time.
Syngenta is under particular scrutiny at the moment as speculation swirls about potential takeovers in the global crop-chemicals business. The Swiss company revealed its intention to sell the seed assets days after Monsanto withdrew its $46.5 billion takeover bid, which Syngenta had rejected. Syngenta has also received -- and rejected -- an offer from China National Chemical Corp., people with knowledge of the matter said last month. Both DuPont Co. and Dow Chemical Co. have said that they’ve held discussions about deals involving their respective agriculture units.
Source: Bloomberg.com